[4S-(4α,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride

CAS: 13614-98-7

Ref. IN-DA00397Y

Produktinformation

• Name: [4S-(4α,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride
• Synonyme: (2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride, (2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride, (4S,12aS,4aS,5aR)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide Hydrochloride, (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride, 0020414E5U, 10118-90-8 (base), 11006-27-2, 13614-98-7, 2-Naftacenocarboxamida, 4,7-bis (dimetilamino)-1,4,4 a, 5,5 a, 6,11,12 a-octahidro-3, 10,12,12 a-tetrahidroxi-1,11-dioxo-,clorhidrato de ( 1:1), (4S, 4aS, 5AR, 12aS)-, 2-Naphthacenecarboxamide, 4,7- bis(dimethylamino)-1,4,4a,5,5a,6,11,12a- octahydro-3,10,12,12a-tetrahydroxy-1,11dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5aalpha,12aalpha)], 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, (4S,4aS,5aR,12aS)-, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5aalpha,12aalpha))-, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, [4S-(4.alpha.,4a.alpha.,5a.alpha.,12a.alpha.)]-, 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, 614M987, 7-Dimethylamino-6-demethyl-6-deoxytetracycline, HCl, AB1009463, AC-22362, AC1NQY0N, AC1NSG07, ACN-031833, AKOS015951312, Acnez, Akamin, Akne Puren, Akne-Puren, Aknemin, Aknin Mino, Aknin-Mino, Aknosan, Apo Minocycline, Apo-Minocycline, Arestin, Arestin, Arestin (TN), B1791, BC207859, BCP06597, Blemix, C18H22O7, C23-H27-N3-O7.Cl-H, C23H27N3O7.ClH, C23H27N3O7.HCl, C23H28ClN3O7, CAS-13614-98-7, CCG-40107, CHEBI:50697, CHEMBL1200881, CID5281093, CID5362501, CS-1256, CS-O-01831, Cyclomin, Cyclops, D00850, DSSTox_CID_24545, DSSTox_GSID_44545, DSSTox_RID_80306, DTXSID8044545, Dentomycin, Dynacin, Dynacin, Dynacin (TN), EINECS 237-099-7, FT-0082736, FT-0601821, FXFM-244, GLMUAFMGXXHGLU-VQAITOIOSA-N, HMS1568P12, HY-17412, Hydrochloride, Minocycline, Icht Oral, Icht-Oral, J10198, KS-00000XT8, Klinomycin, Klinomycin, LS-91518, LS-93852, Lederderm, Lederderm, M2288, MFCD00083669, MINO, MINOCYCLINE HYDROCHLORIDE, MLS002548863, Mestacine, Minakne, Mino Wolff, Mino-Wolff, Minocin, Minocin, Minocin (TN), Minocin MR, Minoclir, Minocycline, Minocycline (hydrochloride), Minocycline HCl, Minocycline Hydrochloride, Minocycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material, Minocycline Monohydrochloride, Minocycline chloride, Minocycline hydrochloride (JP17/USP), Minocycline hydrochloride (internal use), Minocycline hydrochloride [USAN:JAN], Minocycline hydrochloride [USP:JAN], Minocycline hydrochloride, 97%, Minocycline hydrochloride, 98% - 1G 1g, Minocycline hydrochloride, Antibiotic for Culture Media Use Only, Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard, Minocycline hydrochloride, United States Pharmacopeia (USP) Reference Standard, Minocycline hydrochloride, crystalline, Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer, Minocycline, HCl, Minocycline, Hydrochloride, Minocyclinhydrochlorid, Minolis, Minomax, Minomycin, Minomycin, Minomycin chloride, Minoplus, Minotab, Minox 50, Monohydrochloride, Minocycline, Mynocine, Mynocine, Mynocine hydrochloride, NC00460, NCGC00094135-01, NCGC00096006-01, NCGC00178854-03, NCGC00255988-01, NSC 141993, NSC-757120, NSC757120, Periocline, Pharmakon1600-01500414, Prestwick_626, Q-201407, S051, SC-19210, SCHEMBL2537, SMR001906766, SPECTRUM1500414, SR-01000075625, SR-01000075625-1, ST24034766, Solodyn, Solodyn (TN), Tox21_111250, Tox21_111250_1, Tox21_113183, Tox21_301590, Tri-mino, Tri-minocycline, UNII-0020414E5U, UNII-437X58N9AU, Vectrin, W-5076, Ximino, [4S-(4?,4a?,5a?,12a?)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide, [4S-(4a,4aa,5aa,12aa)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a,tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide, [4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride;[4S-(4alpha,4aalpha,5aalpha,12aalpha)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride, [4S-(4|A,4a|A,5a|A,12a|A)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydro-1,11-dioxo-2-naphthacenecarboxamide Hydrochloride, [4S-(4|A,4a|A,5a|A,12a|A)]-4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxonaphthacene-2-carboxamide monohydrochloride, minocycline, minocycline-hcl, minocyclinehydrochloridehydrate, minomycin hydrochloride, s4226, (2E,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione hydrochloride, (2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5a,6,12a-tetrahydrotetracene-1,3,12(2H,4H,5H)-trione hydrochloride, (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride (1:1), (4S-(4Alpha,4Aalpha,5Aalpha,12Aalpha))-4,7-Bis(Dimethylamino)-1,4,4A,5,5A,6,11,12A-Octahydro-3,10,12,12A-Tetrahydroxy-1,11-Dioxonaphthacene-2-Carboxamide Monohydrochloride, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, hydrochloride (1:1), (4S,4aS,5aR,12aS)-, 2-Naphthacenecarboxamide, 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5aα,12aα)]-, 4,7-Bis(Dimethylamino)-3,10,12,12A-Tetrahydroxy-1,11-Dioxo-1,4,4A,5,5A,6,11,12A-Octahydrotetracene-2-Carboxamide, Minocyclin HCl, Minocycline HCL, Periofeel, Minocycline hydrochloride
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 493.9373
• Formel: C₂₃H₂₈ClN₃O₇
• Reinheit: 99%
• Farbe/Form: Solid
• InChl: InChI=1S/C23H27N3O7.ClH/c1-25(2)12-5-6-13(27)15-10(12)7-9-8-11-17(26(3)4)19(29)16(22(24)32)21(31)23(11,33)20(30)14(9)18(15)28;/h5-6,9,11,17,27-28,31,33H,7-8H2,1-4H3,(H2,24,32);1H/t9-,11-,17-,23-;/m0./s1
• InChI Key: WTJXVDPDEQKTCV-VQAITOIOSA-N